Our Research Focus
Synthetic chemistry has the power to enable far-reaching investigations into human biology. Research in the Spiegel lab focuses on organic synthesis, with a specific emphasis on developing new methods and molecules that will facilitate our understanding and treatment of human disease. Ongoing projects range from synthetic reaction development and natural product synthesis to the construction of functional molecules capable of accomplishing specific biological tasks.
Announcements
OCTOBER, 2009
The group reports a novel small-molecule-based strategy for enhancing immune recognition of HIV. Congratulations to graduate student Chris Parker! JACS ASAP
SEPTEMBER, 2009
Welcome to new postdoctoral researcher Chuck Jakobsche, coming from Scott Miller's group at Yale, and visiting researcher Alex Chamessian from Stony Brook University.
APRIL, 2009
David Spiegel has received a Bill & Melinda Gates Foundation Grand Challenges Explorations award for innovation in global health research .
January, 2009
The Spiegel Group welcomes new graduate student group members Eugene Douglass, Taehan (Phil) Kim and Maria Noy.
OCTOBER, 2008
The Spiegel Group welcomes postdoctoral researcher Rendy Kartika, coming from
Richard E. Taylor's group at University of
Notre Dame.
SEPTEMBER, 2008
Congratulations David on being named one of this year’s recipients of the Ellison Medical Foundation New Scholar Award!
July, 2008
Welcome to postdoctoral researcher Mariya
Kolesnikova, who comes to us from Seiichi
Matsuda's group at Rice University.
September, 2007
David Spiegel was recently named one of the first recipients of the NIH Director’s New Innovator Award.
March, 2008
Welcome to new group members Chris Parker, Alison Wendlandt, Andrew Zhang, James Nelson, and Patrick McEnaney!
